Medtronic plc
MDT- Exchange
- NYSE
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001613103
In the last 90 days, Medtronic plc insiders filed 0 open-market purchases and 2 sales; 2,149 institutions reported holding it in 13F filings for Q2 2026, worth $87.9B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Medtronic plc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 2 filings
- 2 insiders, $396.8K in total
- Insiders trading
- 2
- Net value
- −$396.8K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Medtronic plc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Kiil Harry Skip | EVP & President Cardiovascular | 42,186 | Sep 17, 2026 | 7 |
| Blomquist Denise L. | Chief Accounting Officer | 16,398 | Sep 16, 2026 | 8 |
| Marinaro Michael | EVP, Pres MedSurg and Americas | 116,336 | Aug 24, 2026 | 5 |
| Walter Matthew R. | SVP, Chief HR Officer | 39,928 | Aug 4, 2026 | 5 |
| Thompson Kweli | EVP & President, Neuroscience | 35,390 | Aug 4, 2026 | 1 |
| Quinn Michelle | EVP, GC and Secretary | 26,721 | Aug 4, 2026 | 2 |
| Pieton Thierry | EVP & Chief Financial Officer | 49,645 | Aug 4, 2026 | 2 |
| Martha Geoffrey | Chairman and CEO | 327,866 | Aug 4, 2026 | 4 |
| Wall Brett A. | EVP & Pres Neuroscience | 82,183 | May 28, 2026 | 2 |
| Arnold Craig | Director | 42,185 | Apr 29, 2026 | 1 |
| Hogan Randall J | Director | 48,998 | Apr 29, 2026 | 1 |
| Jellison William R | Director | 6,444 | Apr 29, 2026 | 1 |
| Donnelly Scott C | Director | 23,679 | Apr 29, 2026 | 1 |
| Powell Kendall J | Director | 51,380 | Apr 29, 2026 | 1 |
| Fonseca Lidia | Director | 7,644 | Apr 29, 2026 | 1 |
| Lofton Kevin E | Director | 10,140 | Apr 29, 2026 | 1 |
| Groetelaars John P | Director | 1,444 | Apr 29, 2026 | 1 |
| Nabel Elizabeth G | Director | 19,584 | Apr 29, 2026 | 1 |
| Lewis Gregory P | Director | 5,754 | Apr 29, 2026 | 1 |
| Lee Joon Sup | Director | 1,803 | Apr 29, 2026 | 1 |
| Smith Gregory L | EVP Global Ops & Supply Chain | 46,016 | Nov 21, 2025 | 1 |
| Goldsmith Andrea Jo | Director | 10,247 | Apr 30, 2025 | 0 |
| Corona Gary Louis | Interim CFO | 44,255 | Jan 23, 2025 | 0 |
| Fong Ivan K | EVP GENERAL COUNSEL & SECR | 54,692 | Dec 17, 2024 | 0 |
| Salmon Sean | EVP & President Cardiovascular | 64,722 | Dec 17, 2024 | 0 |
| Kirk Jennifer M | Chief Accounting Officer | 28,011 | Dec 10, 2024 | 0 |
| Parkhill Karen L | EVP & Chief Financial Officer | 46,730 | Aug 6, 2024 | 0 |
| Oleary Denise M | Director | 77,057 | May 3, 2024 | 0 |
| White Robert John | EVP & Pres. Medical Surgical | 48,410 | Dec 12, 2023 | 0 |
| Ten Hoedt Rob | EVP and Pres. Global Regions | 52,748 | Aug 7, 2023 | 0 |
| Anderson Richard H | Director | 113,023 | May 3, 2023 | 0 |
| Surface Carol A | EVP, Chief HR Officer | 26,193 | Aug 3, 2022 | 0 |
| Liddicoat John R | EVP & President of Americas | 37,374 | Aug 2, 2022 | 0 |
| Kuntz Richard | SVP & Chief Medical & Science | 74,945 | Nov 9, 2021 | 0 |
| Lerman Bradley E | SVP General Counsel & Corp Sec | 48,635 | Nov 9, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 17, 2026 (view filing)4:17 PM ET | Sep 16 | 1 day | Kiil Harry SkipEVP & President Cardiovascular | SSale | −1.48K | $93.65 | −$138.9K | −3.4%42.2K after | |
| Jul 9, 2026 (view filing)4:26 PM ET | Jul 8 | 1 day | Walter Matthew R.SVP, Chief HR Officer | SSale | −3.10K | $83.15 | −$257.9K | −8.0%35.7K after | 10b5-1 |
| Jun 9, 2026 (view filing) | Jun 8 | 1 day | Kiil Harry SkipEVP & President Cardiovascular | SSale | −4.19K | $80.44 | −$337.0K | −10.1%37.2K after | 2 lots |
| Feb 26, 2026 (view filing) | Feb 19 | 7 daysLate | Kiil Harry SkipEVP & President Cardiovascular | SSale | −52.5K | $97.71 | −$5.13M | −61.6%32.8K after | 5 lots |
| Nov 21, 2025 (view filing) | Nov 19 | 2 days | Smith Gregory LEVP Global Ops & Supply Chain | SSale | −30.0K | $101.95 | −$3.06M | −39.5%46.0K after | 7 lots |
| Sep 5, 2025 (view filing) | Sep 3 | 2 days | Kiil Harry SkipEVP & President Cardiovascular | SSale | −8.61K | $91.58 | −$788.0K | −19.5%35.6K after | 2 lots |
| Aug 25, 2025 (view filing) | Aug 22-25 | 3 days | Jellison William RDirector | PPurchase | +5.00K | $92.55 | +$462.8K | New position5.00K after | 2 lots |
| Jan 27, 2025 (view filing) | Jan 24 | 3 days | Wall Brett A.EVP & Pres Neuroscience | SSale | −12.4K | $90.00 | −$1.12M | −23.3%41.0K after | 10b5-1 |
| Jan 10, 2025 (view filing) | Jan 8 | 2 days | Wall Brett A.EVP & Pres Neuroscience | SSale | −9.85K | $80.41 | −$792.0K | −19.5%40.7K after | 2 lots10b5-1 |
| Jun 11, 2024 (view filing) | Jun 7 | 4 days | Martha GeoffreyChairman and CEO | SSale | −19.1K | $83.77 | −$1.60M | −11.8%143.3K after | 2 lots |
| Apr 9, 2024 (view filing) | Apr 8 | 1 day | Marinaro MichaelEVP & President, Surgical OU | SSale | −854 | $83.14 | −$71.0K | −3.0%27.9K after | |
| Feb 23, 2024 (view filing) | Feb 21 | 2 days | Salmon SeanEVP & President Cardiovascular | SSale | −30.7K | $85.13 | −$2.61M | −38.9%48.3K after | 3 lots |
| Dec 20, 2023 (view filing) | Dec 19 | 1 day | Wall Brett A.EVP & Pres Neuroscience | SSale | −5.00K | $82.17 | −$410.6K | −14.7%28.9K after | 10b5-1 |
| Aug 25, 2023 (view filing) | Aug 23 | 2 days | Smith Gregory LEVP Global Ops & Supply Chain | SSale | −10.0K | $83.84 | −$838.4K | −17.6%46.7K after | |
| Aug 16, 2023 (view filing) | Aug 14 | 2 days | Wall Brett A.EVP & Pres Neuroscience | SSale | −1.00K | $83.38 | −$83.4K | −2.9%33.6K after | 10b5-1 |
| Aug 7, 2023 (view filing) | Aug 4 | 3 days | Marinaro MichaelEVP & President, Surgical OU | SSale | −1.35K | $84.11 | −$113.7K | −4.5%28.9K after | 10b5-1 |
| Jul 18, 2023 (view filing) | Jul 14 | 4 days | Wall Brett A.EVP & Pres Neuroscience | SSale | −2.00K | $87.97 | −$175.9K | −7.7%23.9K after | 10b5-1 |
| Jul 12, 2023 (view filing) | Jul 10 | 2 days | Ten Hoedt RobEVP and Pres. Global Regions | SSale | −5.51K | $86.58 | −$477.4K | −11.2%43.8K after | 2 lots |
| Dec 16, 2022 (view filing) | Dec 13 | 3 daysLate | Salmon SeanEVP & President Cardiovascular | SSale | −16.6K | $80.50 | −$1.34M | −31.5%36.1K after | |
| Oct 17, 2022 (view filing) | Oct 14 | 3 days | Ten Hoedt RobEVP and Pres. Global Regions | SSale | −2.40K | $81.54 | −$196.0K | −5.2%43.5K after | |
| Mar 21, 2022 (view filing) | Mar 18 | 3 days | Parkhill Karen LEVP & Chief Financial Officer | SSale | −682 | $110.00 | −$75.0K | −1.9%34.9K after | |
| Mar 14, 2022 (view filing) | Mar 11 | 3 days | Surface Carol ASVP, Chief HR Officer | SSale | −6.00K | $105.30 | −$631.8K | −17.4%28.5K after | |
| Dec 27, 2021 (view filing) | Dec 23 | 4 days | White Robert JohnEVP & Pres. Medical Surgical | SSale | −7.22K | $102.04 | −$736.5K | −15.5%39.4K after | |
| Dec 17, 2021 (view filing) | Dec 16 | 1 day | Anderson Richard HDirector | PPurchase | +5.01K | $103.26 | +$517.3K | +4.8%108.4K after | |
| Dec 7, 2021 (view filing) | Dec 6 | 1 day | Parkhill Karen LEVP & Chief Financial Officer | SSale | −682 | $110.00 | −$75.0K | −1.9%35.4K after | |
| Oct 1, 2021 (view filing) | Sep 30 | 1 day | Lerman Bradley ESVP General Counsel & Corp Sec | SSale | −49.1K | $126.58 | −$6.22M | −50.2%48.8K after | |
| Sep 1, 2021 (view filing) | Aug 31 | 1 day | Lerman Bradley ESVP General Counsel & Corp Sec | SSale | −50.8K | $134.17 | −$6.81M | −51.0%48.8K after | |
| Aug 26, 2021 (view filing) | Aug 25 | 1 day | Salmon SeanEVP & Pres Diabetes/Cardiovasc | SSale | −28.4K | $134.08 | −$3.81M | −46.0%33.3K after | 2 lots |
| Aug 26, 2021 (view filing) | Aug 25 | 1 day | Martha GeoffreyCEO | SSale | −11.6K | $132.67 | −$1.54M | −10.8%95.8K after | 2 lots |
| Aug 4, 2021 (view filing) | Aug 2 | 2 days | Lerman Bradley ESVP General Counsel & Corp Sec | SSale | −4.00K | $131.52 | −$526.1K | −7.7%48.2K after |